Literature DB >> 9257878

Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986-1995.

F W Dawkins1, K S Kim, R S Squires, R Chisholm, J A Kark, E Perlin, O Castro.   

Abstract

The incidence of cancer in patients with sickle cell disease (SCD) is not known. The 10-year follow-up data on 696 patients with SCD was analyzed at our institution in order to determine the cancer incidence and cancer mortality rates. The age range was 18 to 79 years, with a mean age of 28.8 years. There were 377 females and 319 males. The median follow-up was 3 years. Five patients developed cancer during this period. The cancer incidence rate was 5/2,864 or 1.74 per 1,000 patient years. The 95% CI was 0.64 to 4.32 per 1,000 patient years. There were 68 deaths with 3 being due to cancer. The cancer mortality rate was 3/2,873 or 1.04 cases per 1,000 patient years. Our data represent the first published paper that the authors are aware of, where the cancer incidence and mortality rates have been calculated for any group of patients with SCD.

Entities:  

Mesh:

Year:  1997        PMID: 9257878     DOI: 10.1002/(sici)1096-8652(199707)55:4<188::aid-ajh4>3.0.co;2-o

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.

Authors:  Olena O Seminog; Oyindamola I Ogunlaja; David Yeates; Michael J Goldacre
Journal:  J R Soc Med       Date:  2016-06-20       Impact factor: 5.344

Review 2.  How I use hydroxyurea to treat young patients with sickle cell anemia.

Authors:  Russell E Ware
Journal:  Blood       Date:  2010-03-11       Impact factor: 22.113

3.  Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia.

Authors:  H R Ahmad; J A Faruk; M A Bugaje; A Solomon; M O A Samaila; R M Akuse
Journal:  Case Rep Oncol Med       Date:  2017-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.